U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), And Segment Forecasts, 2025 - 2030
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), And Segment Forecasts, 2025 - 2030
Electro-medical And Electrotherapeutic Apparatus Market Growth & Trends
The global electro-medical and electrotherapeutic apparatus market size is anticipated to reach USD 95.5 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to grow at a CAGR of 6.4% from 2025 to 2030. Key factors driving market growth include the increasing geriatric population, advancements in technology, rising awareness among patients about diagnostic and treatment options, and the growing prevalence of various chronic disorders. For instance, the International Agency for Research on Cancer reported approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths worldwide in 2022.
The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates the need for effective diagnostic and treatment solutions. Electro-medical and electrotherapeutic apparatus play a crucial role in addressing this need by offering efficient and advanced devices that support accurate diagnoses, monitor patient conditions, and deliver therapeutic treatments. These devices are essential in improving patient outcomes and managing chronic conditions more effectively. Advancements in technology is further expected to contribute to overall market growth. For instance, in April 2024, Soterix Medical Inc., a global leader in non-invasive brain stimulation and complementary monitoring technologies, announced the launch of the MxN-GO EEG. This innovative system combines High-Definition transcranial Electrical Stimulation (HD-tES) with EEG, featuring a unique untethered design.
Strategic initiatives by key market players, such as mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, research and development (R&D) efforts, and expansion, are essential in driving the growth of the market. For example, in July 2024, Philips, a global leader in health technology, announced a partnership with Star Imaging in Pune to establish a first-of-its-kind MRI Training School in India. This institution will offer internationally recognized training on MRI technologies across 17 sub-specialties.
Electro-Medical And Electrotherapeutic Apparatus Market Report Highlights
In 2024, the diagnostic segment dominated the product segment by capturing a share of 37.9%.
The therapeutic equipment segment is anticipated to grow at the fastest CAGR during the forecast period.
Cardiology segment held the largest market share in the application segment by capturing a revenue share of 26.9% in 2024.
The neurology segment is expected to grow at the fastest rate during the forecast period.
Among end use, hospitals held a majority share of the market of 46.5% in 2024.
The ambulatory surgical centers segment is expected to grow at the fastest rate over the forecast period.
North America dominated the market with a share of 47.0% in 2024.
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Technology Segment Snapshot
2.3. Application Segment Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Emerging chronic diseases patients
3.2.1.2. Increasing number of new FDA injectable generics drugs approvals
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of injectable
3.3. SWOT Analysis, by Factor
3.4. Industry Analysis- Porter’s
3.5. Consumer Behavior Analysis
3.6. Target Disease Population
3.7. Regulatory Scenario
3.8. Reimbursement Scenario
3.9. Unmet Needs and Opportunity Analysis
Chapter 4. Type Business Analysis
4.1. U.S. IVD & LDT For Autoimmune Diseases Market: Type Movement Analysis